Altria Enters Memorandum of Understanding With KT&G to Pursue Long-term Adjacent Growth
The MOU aligns with Altria’s pursuit of its long-term adjacent growth goals in international innovative smoke-free products and non-nicotine products that we announced in
“We are excited to collaborate with KT&G and their strengths across innovative nicotine and non-nicotine products,” said
“Through our collaboration, we secured a path to growth in next-generation tobacco products by expanding our business from cigarettes to nicotine pouches and other areas,” stated KT&G CEO Kyung-man Bang. “KT&G and
Modern Oral
-
As an initial step in this exploration, an
Altria subsidiary signed a definitive agreement with KT&G whereby, concurrent with KT&G’s acquisition ofAnother Snus Factory Stockholm AB (ASF), a Nordic-based nicotine pouch company, Altria’s subsidiary will acquire an ownership interest in ASF. ASF owns the LOOP brand internationally.
Non-nicotine
An
Enhancing Operational Efficiency
In addition to the focus on innovative nicotine and non-nicotine products,
About KT&G
KT&G is the number one Korean tobacco manufacturer and one of the global Top 5 tobacco companies. KT&G exports “ESSE” and other brands to 140 countries. Its business areas include tobacco, health functional foods, pharmaceuticals, and cosmetics. The company is advancing its future growth through active global expansion in the cigarette and heated tobacco spaces. Furthermore, through its subsidiary KGC, the company continues to expand its Korean and international health functional foods business with emphasis on its premium red ginseng brand “Jung Kwan Jang”.
Altria’s Profile
We have a leading portfolio of tobacco products for
Our wholly owned subsidiaries include leading manufacturers of both combustible and smoke-free products. In combustibles, we own
Additionally, we have a majority-owned joint venture,
Our equity investments include Anheuser-Busch InBev SA/NV (ABI), the world’s largest brewer, and Cronos Group Inc. (Cronos), a leading Canadian cannabinoid company.
The brand portfolios of our operating companies include Marlboro®, Black & Mild®,
Learn more about
Forward Looking and Cautionary Statements
This release contains certain forward-looking statements with respect to Altria’s wholly-owned products and the strategic collaboration with KT&G relating to long-term growth opportunities with modern oral nicotine products and non-nicotine products and the pursuit of enhanced operating efficiency in traditional tobacco products, which are subject to various risks and uncertainties. Such forward looking statements relate to, among other things, the expansion of Altria’s wholly-owned nicotine pouch products in select international markets, potential strategic transactions in the modern oral space, the exploration of business opportunities in the
Factors that may cause actual results to differ include changes in the global demand for nicotine pouch products, non-nicotine products in the energy and wellness segment and traditional tobacco products, the receipt of regulatory authorizations, risks relating to our ability to realize the anticipated benefits of the transactions and future collaboration in the expected manner or timeframe, if at all, prevailing economic, market, regulatory or business conditions, or changes in such conditions, negatively affecting the parties or their plans for future collaboration, the outcome of any legal proceedings or investigations that may be instituted against the parties or others related to the transaction, significant changes in price, availability or quality of raw materials or component parts, including as a result of changes in macroeconomic, climate and geopolitical conditions, ability of
Other risk factors are detailed from time to time in our quarterly reports on Form 10-Q and most recent Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission. These forward-looking statements speak only as of the date of this press release. We assume no obligation to provide any revisions to, or update, any projections and forward-looking statements contained in this release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250922657309/en/
Investor Relations
804-484-8222
Media Relations
804-484-8897
www.altria.com/contact-us/media
Source: